{"id":275155,"date":"2026-09-28T14:07:37","date_gmt":"2026-09-28T08:37:37","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=275155"},"modified":"2026-09-28T14:07:37","modified_gmt":"2026-09-28T08:37:37","slug":"zydus-lifesciences-share-price-usfda","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/","title":{"rendered":"Zydus Lifesciences Hits a Fresh 52-Week High After a Clean USFDA Inspection With Zero Observations in New Jersey"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Zydus Lifesciences Rs 1,214.80, up 0.91% (28 Sep, 1:50 PM). 52-week high Rs 1,228. USFDA inspection: nil observations. RSI 66.4. P\/E 26.11 vs industry 38.42.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The Zydus Lifesciences share price was Rs 1,214.80 at 1:50 PM on 28 September 2026, up 0.91 percent, after touching a fresh 52-week high of about Rs 1,228 following a USFDA inspection that ended with nil observations. The agency inspected the company&#8217;s pharmacovigilance and post-marketing surveillance systems at its New Jersey office from 22 to 25 September. The scope is a safety-reporting office and not a manufacturing plant, so it does not clear the company&#8217;s factories. Volume is about 2.2 times the five-day average, and the RSI of 66.4 is close to but below the overbought line of 70.<\/p>\n<\/div>\n<p>Zydus Lifesciences Limited said the US Food and Drug Administration conducted an on-site inspection of its pharmacovigilance and post-marketing surveillance systems at its office in New Jersey from 22 to 25 September 2026. The inspection concluded with nil observations, which means the agency did not list any deficiencies.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=zydus-lifesciences-share-price-usfda\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<p>The stock rose to a high of Rs 1,228.40 and traded on heavy volume. This article explains what the inspection covers, why it matters less than a plant inspection, and where the Zydus Lifesciences share price stands.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/#What_the_New_Jersey_USFDA_Inspection_Covers\" title=\"What the New Jersey USFDA Inspection Covers\">What the New Jersey USFDA Inspection Covers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/#Zydus_Lifesciences_Share_Price_Today_Numbers_and_Technical_Levels\" title=\"Zydus Lifesciences Share Price Today: Numbers and Technical Levels\">Zydus Lifesciences Share Price Today: Numbers and Technical Levels<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/#Valuation_and_Financial_Strength_Behind_the_Zydus_Lifesciences_Share_Price\" title=\"Valuation and Financial Strength Behind the Zydus Lifesciences Share Price\">Valuation and Financial Strength Behind the Zydus Lifesciences Share Price<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/#Risks_for_the_Zydus_Lifesciences_Share_Price\" title=\"Risks for the Zydus Lifesciences Share Price\">Risks for the Zydus Lifesciences Share Price<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/#What_is_the_Zydus_Lifesciences_share_price_today\" title=\"What is the Zydus Lifesciences share price today?\">What is the Zydus Lifesciences share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/#What_did_the_USFDA_inspect_at_Zydus_in_New_Jersey\" title=\"What did the USFDA inspect at Zydus in New Jersey?\">What did the USFDA inspect at Zydus in New Jersey?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/#What_does_nil_observations_mean\" title=\"What does nil observations mean?\">What does nil observations mean?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/#Does_the_inspection_clear_Zydus_manufacturing_plants\" title=\"Does the inspection clear Zydus manufacturing plants?\">Does the inspection clear Zydus manufacturing plants?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/#Why_is_the_Zydus_Lifesciences_share_price_at_a_52-week_high\" title=\"Why is the Zydus Lifesciences share price at a 52-week high?\">Why is the Zydus Lifesciences share price at a 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/#What_are_the_key_technical_levels_for_the_Zydus_Lifesciences_share_price\" title=\"What are the key technical levels for the Zydus Lifesciences share price?\">What are the key technical levels for the Zydus Lifesciences share price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/#Is_the_Zydus_Lifesciences_share_price_expensive\" title=\"Is the Zydus Lifesciences share price expensive?\">Is the Zydus Lifesciences share price expensive?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/zydus-lifesciences-share-price-usfda\/#Should_I_buy_Zydus_Lifesciences_shares_at_the_high\" title=\"Should I buy Zydus Lifesciences shares at the high?\">Should I buy Zydus Lifesciences shares at the high?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_the_New_Jersey_USFDA_Inspection_Covers\"><\/span><strong>What the New Jersey USFDA Inspection Covers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellpadding=\"6\" style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"text-align:left;\">Item<\/th>\n<th style=\"text-align:left;\">Detail<\/th>\n<\/tr>\n<tr>\n<td>Regulator<\/td>\n<td>US Food and Drug Administration<\/td>\n<\/tr>\n<tr>\n<td>Site<\/td>\n<td>Company office in New Jersey<\/td>\n<\/tr>\n<tr>\n<td>Scope<\/td>\n<td>Pharmacovigilance and post-marketing surveillance systems<\/td>\n<\/tr>\n<tr>\n<td>Dates<\/td>\n<td>22 to 25 September 2026<\/td>\n<\/tr>\n<tr>\n<td>Outcome<\/td>\n<td>Nil observations<\/td>\n<\/tr>\n<\/table>\n<p>Pharmacovigilance covers how a company collects, assesses and reports adverse events for drugs already on the market, including reports from doctors, patients and regulators across every country where the products are sold. A clean result shows the safety-reporting system meets US expectations, which is a useful signal for the company&#8217;s US business.<\/p>\n<p>It does not cover manufacturing quality. Zydus received a warning letter for its Baddi formulation plant in June 2026, when the stock fell 2.24 percent to Rs 1,053.10, so plant inspections remain the bigger driver of the Zydus Lifesciences share price.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/nifty-below-23000\">Nifty Slips Below 23,000 as Sensex Tests Its Support Zone: What Drove the Selloff and What to Watch<\/a><\/p>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Zydus_Lifesciences_Share_Price_Today_Numbers_and_Technical_Levels\"><\/span><strong>Zydus Lifesciences Share Price Today: Numbers and Technical Levels<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table border=\"1\" cellpadding=\"6\" style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"text-align:left;\">Metric<\/th>\n<th style=\"text-align:left;\">Value (28 Sep, 1:50 PM)<\/th>\n<\/tr>\n<tr>\n<td>Zydus Lifesciences share price<\/td>\n<td>Rs 1,214.80 (up 0.91%)<\/td>\n<\/tr>\n<tr>\n<td>Previous close<\/td>\n<td>Rs 1,203.90<\/td>\n<\/tr>\n<tr>\n<td>Day range<\/td>\n<td>Rs 1,201.20 to Rs 1,228.40<\/td>\n<\/tr>\n<tr>\n<td>Volume so far<\/td>\n<td>31.25 lakh shares<\/td>\n<\/tr>\n<tr>\n<td>Five-day average volume<\/td>\n<td>14.31 lakh shares<\/td>\n<\/tr>\n<tr>\n<td>RSI (14-day)<\/td>\n<td>66.4<\/td>\n<\/tr>\n<tr>\n<td>MACD vs signal line<\/td>\n<td>14.32 vs 5.92<\/td>\n<\/tr>\n<tr>\n<td>SuperTrend<\/td>\n<td>Bullish, support at Rs 1,134.49<\/td>\n<\/tr>\n<tr>\n<td>20-day average<\/td>\n<td>Rs 1,150.35<\/td>\n<\/tr>\n<tr>\n<td>Market cap (Friday close)<\/td>\n<td>Rs 1,19,900 crore<\/td>\n<\/tr>\n<tr>\n<td>P\/E vs industry P\/E<\/td>\n<td>26.11 vs 38.42<\/td>\n<\/tr>\n<\/table>\n<p>The Zydus Lifesciences share price is 5.6 percent above its 20-day average of Rs 1,150.35 and has gained 15.4 percent since the Rs 1,053.10 level of 3 June, when the Baddi warning letter hit the stock. The MACD line is well above its signal line, a bullish sign of strong momentum.<\/p>\n<p>An RSI of 66.4 leaves limited room before the overbought zone for the Zydus Lifesciences share price, and volume of 2.2 times the five-day average shows real participation. The SuperTrend indicator shows support at Rs 1,134.49.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare Pharma Valuations on the Univest Screener<\/strong><\/a><\/p>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Valuation_and_Financial_Strength_Behind_the_Zydus_Lifesciences_Share_Price\"><\/span><strong>Valuation and Financial Strength Behind the Zydus Lifesciences Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Zydus trades at a P\/E of 26.11 against an industry figure of 38.42, with a return on equity of 18.59 percent and a debt to equity of 0.46. Price to book is 4.42 and the dividend yield is 0.08 percent. Trailing earnings are Rs 46.04 per share, so at Rs 1,214.80 investors pay about 26 times earnings, and the market value is close to Rs 1.2 lakh crore. Those figures show why the Zydus Lifesciences share price is seen as a large, steady pharma name and not a speculative one.<\/p>\n<p>The company approved a buyback of Rs 1,100 crore alongside its Q4 FY26 results in May 2026, when profit after tax rose 9 percent year on year. A buyback supports the Zydus Lifesciences share price by reducing the share count, and it signals management&#8217;s view of value. Zydus also has a large domestic business and a specialty pipeline that includes biosimilars, which spreads risk beyond one US plant or one inspection outcome.<\/p>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Risks_for_the_Zydus_Lifesciences_Share_Price\"><\/span><strong>Risks for the Zydus Lifesciences Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Plant compliance is the main risk. The Baddi warning letter in June 2026 and an Official Action Indicated classification for its Jarod injectables plant in 2024 show that inspection outcomes can swing the Zydus Lifesciences share price quickly.<\/p>\n<p>Momentum is the second. After a 15 percent run in under four months and a fresh 52-week high, the stock is vulnerable to profit taking, especially with the market weak. US pricing pressure on generics is the third risk.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/us-iran-peace-talks-oil-price\">Trump Rejects Iran&#8217;s Peace Proposal: Oil Climbs, the Dollar Firms and Gold Falls as Rate-Hike Bets Build<\/a><\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track the Zydus Lifesciences share price and get alerts on USFDA inspections.<\/em><\/p>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Zydus Lifesciences share price of Rs 1,214.80 is near a 52-week high after a clean pharmacovigilance inspection, but the check covers safety reporting and not factories. A P\/E of 26.11 against 38.42 for the industry, an 18.59 percent return on equity and a Rs 1,100 crore buyback are supports, while plant compliance history and stretched momentum are risks. Investors deciding whether to buy Zydus Lifesciences shares should watch the Rs 1,134.49 support, follow stop-loss levels and consult a SEBI-registered adviser.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data independently before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_is_the_Zydus_Lifesciences_share_price_today\"><\/span><strong>What is the Zydus Lifesciences share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Zydus Lifesciences share price was Rs 1,214.80 at 1:50 PM on 28 September 2026, up 0.91 percent from Rs 1,203.90, after touching Rs 1,228.40.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_did_the_USFDA_inspect_at_Zydus_in_New_Jersey\"><\/span><strong>What did the USFDA inspect at Zydus in New Jersey?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The agency inspected pharmacovigilance and post-marketing surveillance systems at the company&#8217;s New Jersey office from 22 to 25 September 2026.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_does_nil_observations_mean\"><\/span><strong>What does nil observations mean?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It means the inspection ended without the agency listing any deficiencies, which is the best possible outcome of an inspection.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Does_the_inspection_clear_Zydus_manufacturing_plants\"><\/span><strong>Does the inspection clear Zydus manufacturing plants?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. The inspection covered safety reporting at an office, not manufacturing plants, so plant compliance is still assessed separately.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Why_is_the_Zydus_Lifesciences_share_price_at_a_52-week_high\"><\/span><strong>Why is the Zydus Lifesciences share price at a 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Zydus Lifesciences share price has risen 15.4 percent since early June, helped by the clean inspection, a buyback and strong momentum.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"What_are_the_key_technical_levels_for_the_Zydus_Lifesciences_share_price\"><\/span><strong>What are the key technical levels for the Zydus Lifesciences share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The key levels for the Zydus Lifesciences share price are SuperTrend support at Rs 1,134.49 and the 20-day average of Rs 1,150.35. The RSI is 66.4.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Is_the_Zydus_Lifesciences_share_price_expensive\"><\/span><strong>Is the Zydus Lifesciences share price expensive?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/E of 26.11 is below the industry figure of 38.42, and return on equity is 18.59 percent, so the stock trades at a discount to the sector.<\/p>\n<h3 style=\"font-weight:700;\"><span class=\"ez-toc-section\" id=\"Should_I_buy_Zydus_Lifesciences_shares_at_the_high\"><\/span><strong>Should I buy Zydus Lifesciences shares at the high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> A fresh high brings profit-taking risk, and the inspection is narrow. Use a stop-loss and consult a SEBI-registered adviser before acting.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Zydus Lifesciences share price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Zydus Lifesciences share price was Rs 1,214.80 at 1:50 PM on 28 September 2026, up 0.91 percent from Rs 1,203.90, after touching Rs 1,228.40.\"}},{\"@type\":\"Question\",\"name\":\"What did the USFDA inspect at Zydus in New Jersey?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The agency inspected pharmacovigilance and post-marketing surveillance systems at the company's New Jersey office from 22 to 25 September 2026.\"}},{\"@type\":\"Question\",\"name\":\"What does nil observations mean?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It means the inspection ended without the agency listing any deficiencies, which is the best possible outcome of an inspection.\"}},{\"@type\":\"Question\",\"name\":\"Does the inspection clear Zydus manufacturing plants?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. The inspection covered safety reporting at an office, not manufacturing plants, so plant compliance is still assessed separately.\"}},{\"@type\":\"Question\",\"name\":\"Why is the Zydus Lifesciences share price at a 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Zydus Lifesciences share price has risen 15.4 percent since early June, helped by the clean inspection, a buyback and strong momentum.\"}},{\"@type\":\"Question\",\"name\":\"What are the key technical levels for the Zydus Lifesciences share price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The key levels for the Zydus Lifesciences share price are SuperTrend support at Rs 1,134.49 and the 20-day average of Rs 1,150.35. The RSI is 66.4.\"}},{\"@type\":\"Question\",\"name\":\"Is the Zydus Lifesciences share price expensive?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The P\/E of 26.11 is below the industry figure of 38.42, and return on equity is 18.59 percent, so the stock trades at a discount to the sector.\"}},{\"@type\":\"Question\",\"name\":\"Should I buy Zydus Lifesciences shares at the high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"A fresh high brings profit-taking risk, and the inspection is narrow. Use a stop-loss and consult a SEBI-registered adviser before acting.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Zydus Lifesciences got nil observations from a USFDA pharmacovigilance inspection and hit a fresh high. Here is what it does and does not mean.<\/p>\n","protected":false},"author":36,"featured_media":275154,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[1007,1019],"class_list":["post-275155","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-pharma-stocks","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["275154"],"rank_math_title":["Zydus Lifesciences Share Price Hits 52-Week High on USFDA Nod"],"rank_math_description":["Zydus Lifesciences share price is Rs 1,214.80, near a 52-week high, after a USFDA inspection ended with nil observations. Technical levels, valuation and risks explained."],"rank_math_focus_keyword":["Zydus Lifesciences share price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/zydus-lifesciences-hits-a-fresh-52-week-high-after-a-clean-usfda-inspection-with.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=275155"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275155\/revisions"}],"predecessor-version":[{"id":275156,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275155\/revisions\/275156"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/275154"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=275155"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=275155"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=275155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}